Published in Biochem Pharmacol on August 17, 1994
Pravastatin provides antioxidant activity and protection of erythrocytes loaded Primaquine. Int J Med Sci (2010) 0.84
Protective effect of flavonoids against red blood cell hemolysis by free radicals. Exp Clin Cardiol (2005) 0.83
Monofloral honeys by Sicilian black honeybee (Apis mellifera ssp. sicula) have high reducing power and antioxidant capacity. Heliyon (2016) 0.75
Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia. Cell (1981) 3.80
A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med (1984) 3.07
Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: a randomized controlled trial. JAMA (1998) 2.83
Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol (1978) 2.07
The present status of the heterogeneity of fetal hemoglobin in beta-thalassemia: an attempt to unify some observations in thalassemia and related conditions. Ann N Y Acad Sci (1974) 1.99
Proliferation and maturation of human erythroid progenitors in liquid culture. Blood (1989) 1.78
Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med (1985) 1.72
The effects of protein conformation on the heme symmetry in high spin ferric heme proteins as studied by electron paramagnetic resonance. J Biol Chem (1971) 1.57
Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL. QJM (2008) 1.56
Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia. N Engl J Med (1993) 1.51
Ovarian tissue banking in patients with Hodgkin's disease: is it safe? Fertil Steril (1998) 1.46
Dietary factors in human colorectal cancer. Annu Rev Nutr (1999) 1.42
Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood (1983) 1.41
Activated oxygen and haemolysis. Br J Haematol (1975) 1.41
Studies on the stability of oxyhemoglobin A and its constituent chains and their derivatives. J Biol Chem (1971) 1.38
Cardiopulmonary assessment in beta-thalassemia major. Chest (1990) 1.26
Oxidative denaturation of red blood cells in thalassemia. Semin Hematol (1990) 1.24
Lipid membrane peroxidation in beta-thalassemia major. Blood (1976) 1.18
Denaturation of the normal and abnormal hemoglobin molecule. Semin Hematol (1974) 1.17
Influence of dietary calcium and vitamin D on diet-induced epithelial cell hyperproliferation in mice. J Natl Cancer Inst (1999) 1.15
Role of haemichromes in the formation of inclusion bodies in haemoglobin H disease. Nature (1969) 1.12
Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases. Ann Oncol (1995) 1.09
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood (1996) 1.08
Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis. Cancer Res (1998) 1.06
Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis (1998) 1.06
beta 0-Thalassemia complicated by autoimmune hemolytic anemia. Globin synthesis during immunosuppressive therapy. Acta Haematol (1980) 1.06
Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow. Isr J Med Sci (1972) 1.05
The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. Br J Haematol (1986) 1.05
Essential cryofibrinogenemia. Clinical, pathological and immunological studies. Isr J Med Sci (1970) 1.05
Gonadotrophin, thyrotrophin and prolactin reserve in beta thalassaemia. Clin Endocrinol (Oxf) (1978) 1.04
In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol (1997) 1.02
A new polymorphism in the human beta-globin gene useful in antenatal diagnosis. J Clin Invest (1981) 1.02
Erythropoietin triggers a burst of GATA-1 in normal human erythroid cells differentiating in tissue culture. Nucleic Acids Res (1993) 1.00
Absence of beta mRNA in beta0-thalassemia in Kurdish Jews. Blood (1978) 1.00
Novel treatment options in the severe beta-globin disorders. Br J Haematol (1995) 0.99
Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia. Blood (1987) 0.99
The demonstration of ferrihemochrome intermediates in heinz body formation following the reduction of oxyhemoglobin A by acetylphenylhydrazone. Biochim Biophys Acta (1975) 0.99
Calcium and the prevention of colon cancer. J Cell Biochem Suppl (1995) 0.98
Superoxide dismutase in red blood cells: method of assay and enzyme content in normal subjects and in patients with beta-thalassemia (major and intermedia). J Lab Clin Med (1976) 0.98
Blood group phenotypes and hemoglobin S. An anthropologic study in two Israeli Arab communities. Acta Haematol (1976) 0.98
Mean corpuscular volume of heterozygotes for beta-thalassemia correlates with the severity of mutations. Blood (1992) 0.98
The two-step liquid culture: a novel procedure for studying maturation of human normal and pathological erythroid precursors. Stem Cells (1993) 0.97
Colonic epithelial cell proliferation in responders and nonresponders to supplemental dietary calcium. Cancer Res (1989) 0.97
Quantitative studies of ferritinlike iron in erythrocytes of thalassemia, sickle-cell anemia, and hemoglobin Hammersmith with Mössbauer spectroscopy. Proc Natl Acad Sci U S A (1979) 0.96
Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol (1993) 0.96
Juvenile leg ulceration in beta-thalassemia major and intermedia. Plast Reconstr Surg (1982) 0.96
Oral beta-carotene can increase the number of OKT4+ cells in human blood. Immunol Lett (1985) 0.96
Induced hyperproliferation in epithelial cells of mouse prostate by a Western-style diet. Carcinogenesis (1997) 0.95
Blood group phenotypes and the origin of sickle cell hemoglobin in Sicilians. Acta Haematol (1978) 0.94
Visceral leishmaniasis: a difficult diagnosis and unusual causative agent. J Infect Dis (1991) 0.94
A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. Br J Haematol (1999) 0.93
Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis (2000) 0.92
Two mutations in the beta-globin polyadenylylation signal reveal extended transcripts and new RNA polyadenylylation sites. Proc Natl Acad Sci U S A (1992) 0.92
Aspirin prevents tumors in a murine model of familial adenomatous polyposis. Surgery (1998) 0.92
Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colon. Cancer Res (1996) 0.91
Enhanced generation of monocyte tissue factor and increased plasma prothrombin fragment1+2 levels in patients with polycythemia vera: mechanism of activation of blood coagulation. Am J Hematol (1997) 0.91
Fecal diglycerides as selective endogenous mitogens for premalignant and malignant human colonic epithelial cells. Cancer Res (1989) 0.91
Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia. J Clin Invest (1989) 0.91
Nonspecific serum iron in thalassemia: quantitation and chemical reactivity. Am J Hematol (1979) 0.91
Expression of granulocytic functions by leukemic promyelocytic HL-60 cells: differential induction by dimethylsulfoxide and retinoic acid. Cell Differ (1987) 0.90
Homozygous beta0- and beta+ - thalassemia in Kurdish Jews and Arabs. Hemoglobin (1977) 0.90
In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood (1991) 0.90
Primary leiomyosarcoma of gallbladder seen on computed tomography and ultrasound. Am J Gastroenterol (1986) 0.90
Ultrastructural studies in -thalassaemia major. Br J Haematol (1973) 0.89
The interaction of hemoglobin O Arab with Hb S and beta+ thalassemia among Israeli Arabs. Hum Genet (1985) 0.89
Formation of hemichromes from oxidized hemoglobin subunits. Ann N Y Acad Sci (1969) 0.89
Epithelial cell hyperproliferation induced in the exocrine pancreas of mice by a western-style diet. J Natl Cancer Inst (1996) 0.89
Self-renewal and commitment to differentiation of human leukemic promyelocytic cells (HL-60). J Cell Physiol (1982) 0.88
Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major. Clin Endocrinol (Oxf) (1993) 0.88
Mechanism of desferrioxamine-induced iron excretion in thalassaemia. Br J Haematol (1979) 0.88
Thromboembolic complications in beta thalassemia major. Acta Haematol (1992) 0.87
Relief of pruritus by cholestyramine in chronic liver disease. Isr J Med Sci (1965) 0.87
Phagocytosis of nucleated and mature beta thalassaemic red blood cells by mouse macrophages in vitro. Br J Haematol (1979) 0.87
Protective effects of tea polyphenols against oxidative damage to red blood cells. Biochem Pharmacol (1997) 0.87
Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis (1992) 0.87
Cross-linking of red blood cell membrane proteins induced by oxidative stress in beta thalassemia. FEBS Lett (1978) 0.86
Splenectomy in homozygous beta thalassaemia: a retrospective study of 30 patients. Br J Haematol (1975) 0.86
Adult and neonatal patterns of human globin gene expression are recapitulated in liquid cultures. Exp Hematol (1992) 0.86
Left ventricular function in beta-thalassemia and the effect of multiple transfusions. Am Heart J (1978) 0.86
Genetic and molecular diversity in nondeletion Hb H disease. Proc Natl Acad Sci U S A (1981) 0.86
Caffeic and ferulic acid as blockers of nitrosamine formation. Carcinogenesis (1984) 0.86
Growth of human normal erythroid progenitors in liquid culture: a comparison with colony growth in semisolid culture. Int J Cell Cloning (1991) 0.85
Vitamin E deficiency in beta-thalassemia major: changes in hematological and biochemical parameters after a therapeutic trial with alpha-tocopherol. Am J Clin Nutr (1979) 0.85
Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo. Blood (1995) 0.85
Isolation, characterization, and immunoprecipitation studies of immune complexes from membranes of beta-thalassemic erythrocytes. Blood (1992) 0.85
An electron microscopic study of the nuclear abnormalities in erythroblasts in beta-thalassaemia major. Br J Haematol (1974) 0.85
Tumour promoters induce macrophage differentiation in human myeloid cells from patients with acute and chronic myelogenous leukaemia. Br J Haematol (1981) 0.84
Haemichrome formation during the in vitro oxidation of Hb Köln. Nat New Biol (1973) 0.84
Dapsone-induced methemoglobinemia and hemolysis in the presence of familial hemoglobinopathy Hasharon and familial methemoglobin reductase deficiency. Isr J Med Sci (1981) 0.84
Sickle cell trait in a white Jewish family presenting as splenic infarction at high altitude. Am J Hematol (1988) 0.84
Preclinical mouse models for cancer chemoprevention studies. Ann N Y Acad Sci (1999) 0.84
Oxidative damage to human red cells induced by copper and iron complexes in the presence of ascorbate. Biochim Biophys Acta (1989) 0.84
Modulation of the maturation of human leukemic promyelocytes (HL-60) to granulocytes or macrophages. Leuk Res (1982) 0.83
Recurrent transient bone marrow hypoplasia associated with pregnancy. Acta Haematol (1993) 0.83
Haemoglobinopathies and red cell membrane function. Baillieres Clin Haematol (1993) 0.83
Vitamins A and E nutrition via intramuscular or oral route. Am J Clin Nutr (1974) 0.83
Erythropoietin activity in the serum of beta thalassemic patients. Scand J Haematol (1986) 0.83
Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. Leuk Lymphoma (1993) 0.83
Beta O-thalassemia intermedia. Blood (1978) 0.83